World Lifestyler
  • Fashion
  • Car Reviews
  • Collectors
  • Luxury Cars
  • Planes
  • Private Jets
  • Yachts
  • Road Trips
  • Fashion
  • Car Reviews
  • Collectors
  • Luxury Cars
  • Planes
  • Private Jets
  • Yachts
  • Road Trips
No Result
View All Result
World Lifestyler
No Result
View All Result
Home Uncategorized

LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Global Partnership Opportunities

Cision PR Newswire by Cision PR Newswire
March 9, 2026
in Uncategorized
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

SEOUL, South Korea, March 9, 2026 /PRNewswire/ — LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global presence in the contract development and manufacturing organization (CDMO) sector.

Lotte Biologics

Held annually in New York, DCAT Week is one of the industry’s most prominent global gatherings, bringing together pharmaceutical companies, CDMOs, and other life sciences stakeholders to discuss collaboration opportunities and industry trends.

During the event, LOTTE Biologics will host a series of meetings at the Lotte New York Palace Hotel, where DCAT Week is held, to engage with potential partners and explore new business opportunities in the global CDMO market, including North America.

The company will highlight the synergy between its Syracuse Bio Campus in New York and the Songdo Bio Campus in Incheon, South Korea, which is scheduled for mechanical completion in August 2026 as part of LOTTE Biologics’ plan to expand its global manufacturing network. By leveraging the dual-site model across the United States and Korea, the company aims to support global partners with flexible and reliable manufacturing capabilities.

LOTTE Biologics will also emphasize the expansion of its service capabilities through strategic collaborations. In particular, through its ongoing collaboration with the U.S.-based cell line development experts Asimov, the company is able to offer end to end DNA to DS services. This collaboration allows for streamlined, unified capabilities with 8.5 month timelines from transfection to drug substance release.

“DCAT Week is an important gathering where key decision-makers across the global pharmaceutical and biotechnology industry come together,” said a representative from LOTTE Biologics. “Through this participation, we aim to actively explore partnership opportunities with potential clients and continue strengthening our competitiveness in the global market.”

Logo – https://mma.prnewswire.com/media/2928734/5852167/new_Lotte_Biologics_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/lotte-biologics-to-participate-in-dcat-week-2026-in-new-york-to-explore-global-partnership-opportunities-302707754.html

Cision PR Newswire

Cision PR Newswire

Related Posts

Ulike Spring: Dare to Glow — Celebrating Confident and Aspirational Women

March 9, 2026

Wilentz, Goldman & Spitzer, P.A. Welcomes Former Presiding Judge Robert J. Mega to the Firm

March 9, 2026

InventHelp Inventor Develops Automatic Nail Care Device (CCT-4883)

March 9, 2026

Residential Home Health Expands Eastern Pennsylvania Footprint with Acquisition of Covenant Home Health

March 9, 2026

Smart Energy Market to Reach US$ 417.7 Billion by 2033 Expands Amid Digital Grid Transformation and Clean Energy Investments – Persistence Market Research

March 9, 2026

SIG SAUER Expands Shooter Affiliate Program to include Sal Hernandez, Ian Meyers, and Kevin Lally

March 9, 2026

Popular News

  • PAAMC HK Wins Dual Honors at Asia Asset Management ETF Awards 2026

    0 shares
    Share 0 Tweet 0
  • Huawei’s Yang Chaobin on Building a Better Intelligent World with 5G-A and U6GHz

    0 shares
    Share 0 Tweet 0
  • Bodycote Plc – Launch of new £80 million Share Buyback Programme

    0 shares
    Share 0 Tweet 0
  • CANAL+ and Google Cloud Form Strategic Partnership on AI

    0 shares
    Share 0 Tweet 0
  • CHF ~65 million investment in 2025: Swiss President Guy Parmelin inaugurates new Toblerone production line in Switzerland

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler